Why does G132N CHIP restore binding in isolated domains but only partially in full-length protein?

The engineered G132N variant fully restores phosphorylated HSP70 binding affinity in isolated TPR domains but shows only partial recovery in full-length CHIP within cells. This suggests unknown structural or regulatory constraints that could be critical for understanding proteostasis dysfunction in disease.

Gap type: unexplained_observation Source paper: Crystal structures reveal phosphorylation-dependent disruption of the heat shock protein 70-CHIP interface: A compensatory G132N variant restores binding affinity. (2026, Cell stress & chaperones, PMID:41833837)

{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:31.742001+00:00”, “resolution_summary”: “Resolved by hypothesis h-5d943bfc: Proteostasis Enhancement via APOE Chaperone Targeting. Supporting evidence includes debate sess_SDA-2026-04-13-gap-pubmed-20260410-145358-185db2c8_20260414-005137.”, “match_counts”: {“hypothesis_matches”: 1, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-5d943bfc”, “title”: “Proteostasis Enhancement via APOE Chaperone Targeting”, “score”: 0.236, “reason”: “25 token overlaps; entity overlap: hsp70”, “analysis_id”: “sda-2026-04-01-gap-auto-fd6b1635d9”, “target_gene”: “HSPA1A”, “target_pathway”: “HSP70/HSP40 chaperone-mediated proteostasis”, “disease”: “neurodegeneration”, “composite_score”: 0.7240110000000001, “confidence_score”: 0.65, “status”: “proposed”, “pubmed_evidence_ids”: [“15537890”, “16157603”, “28916615”, “29566236”, “32554827”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-145358-185db2c8_20260414-005137”, “title”: “The study shows homozygous R136S fully rescues APOE4-driven pathology while heterozygous provides only partial protection, but the mechanistic basis for this gene dosage effect is unexplained. Understanding this mechanism is critical for developing therapeutic strategies that could mimic R136S protection.\n\nGap type: unexplained_observation\nSource paper: The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation. (2023, Nature neuroscience, PMID:37957317)”, “score”: 0.436, “reason”: “13 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-145358-185db2c8”, “quality_score”: 0.81, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-170325-196c7ee5_20260413-235122”, “title”: “The study shows that MCT1 disruption leads to axon degeneration and neuron death, but the specific molecular pathways linking lactate transport dysfunction to neuronal damage remain unexplained. Understanding this mechanism is critical for developing targeted neuroprotective therapies.\n\nGap type: unexplained_observation\nSource paper: Oligodendroglia metabolically support axons and contribute to neurodegeneration. (2012, Nature, PMID:22801498)”, “score”: 0.416, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-170325-196c7ee5”, “quality_score”: 0.82, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-170325-196c7ee5_20260414-001952”, “title”: “The study shows that MCT1 disruption leads to axon degeneration and neuron death, but the specific molecular pathways linking lactate transport dysfunction to neuronal damage remain unexplained. Understanding this mechanism is critical for developing targeted neuroprotective therapies.\n\nGap type: unexplained_observation\nSource paper: Oligodendroglia metabolically support axons and contribute to neurodegeneration. (2012, Nature, PMID:22801498)”, “score”: 0.416, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-170325-196c7ee5”, “quality_score”: 0.78, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-15-gap-pubmed-20260411-080155-ea072afc”, “title”: “The abstract shows that Gal3 binding to pTau greatly enhances tau fibrillation, but the specific molecular interactions and structural changes driving this enhancement are not explained. Understanding this mechanism is critical for developing targeted therapeutics that could disrupt this pathogenic interaction.\n\nGap type: unexplained_observation\nSource paper: Galectin-3 aggravates microglial activation and tau transmission in tauopathy. (2024, The Journal of clinical investigation, PMID:37988169”, “score”: 0.412, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-080155-ea072afc”, “quality_score”: 0.92, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-181258-df5eee45”, “title”: “The study shows that OB microglia phagocytose LC axons before amyloid plaque formation, but the molecular signals that mark these axons for destruction are unknown. Understanding this mechanism could reveal early therapeutic targets to prevent noradrenergic denervation.\n\nGap type: unexplained_observation\nSource paper: Early Locus Coeruleus noradrenergic axon loss drives olfactory dysfunction in Alzheimer’s disease. (2025, Nature communications, PMID:40781079)”, “score”: 0.412, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-181258-df5eee45”, “quality_score”: 0.7, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}